Walking Linked to Less Fatigue in Colorectal Cancer SurvivorshipByAndrea Eleazar, MHSJanuary 12th 2026
Tukysa May Be ‘Patient Friendly’ Frontline Maintenance Option in HER2+ Breast CancerByDr. Erika Hamilton January 12th 2026
Understanding Quality of Life Priorities in Later-Line Colon Cancer ByDr. Thejus Jayakrishnan January 11th 2026
Breaking Down Side Effects of Tukysa in HER2+ Breast CancerByDr. Erika Hamilton ,Dr. Joshua K. SabariJanuary 8th 2026